Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing

Hypertension

Volumn 42, Issue 3, 2003, Pages 263-268

  De Lima, Jose Jayme G ^a   Sabbaga, Emil ^b   Vieira, Marcelo Luis C ^b   De Paula, Flavio J ^b   Ianhez, Luis E ^b   Krieger, Eduardo M ^b   Ramires, Jose Antonio F ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE

Author keywords

Coronary artery disease; Hypertension, essential; Kidney failure; Risk factors; Transplantation

Indexed keywords

DOBUTAMINE;

ADULT; ALGORITHM; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; EXERCISE ELECTROCARDIOGRAPHY; FEMALE; HUMAN; INTERMETHOD COMPARISON; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON INVASIVE MEASUREMENT; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURGICAL RISK; SURVIVAL; TREATMENT PLANNING;

ADULT; CORONARY ANGIOGRAPHY; CORONARY DISEASE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0042835365     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000087889.60760.87     Document Type: Article

References (31)

1. Stewart G, Jardine AG, Briggs JD. Ischaemic heart disease following renal transplantation. Nephrol Dial Transplant. 2000;15:269-277.
2. Rostand SG, Kirk KA, Rutsky EA. Dialysis associated ischemic heart disease: insights from coronary angiography. Kidney Int. 1984;25: 623-629.
3. Manske CL, Thomas W, Wang Y, Wilson RF. Screening diabetic transplant candidates for coronary artery disease; identification of a low risk subgroup. Kidney Int. 1993;44:617-621.
4. Le A, Wilson R, Douek K, Pulliam L, Tolzman D, Norman D, Barry J, Bennett WM. Prospective risk stratification in renal transplant candidates for cardiac death. Am J Kidney Dis. 1994;24:65-71.
5. Reis G, Marcovitz PA, Leitchman AB, Merion RM, Fay WP, Wems SW, Armstrong WF. Usefulness of dobutamine stress echocardiography in detecting coronary artery disease in end-stage renal disease. Am J Cardiol. 1995;75:707-710.
6. Herzog CA, Marwick TH, Pheley AM, White CW, Rao VK, Dick CD. Dobutamine stress echocardiography for the detection of significant coronary artery disease in renal transplant candidates. Am J Kidney Dis. 1999;33:1080-1090.
7. West JC, Napoliello DA, Costello JM, Nassef LA, Butcher RJ, Hartle JE, McConnell TR, Finley JW, Kelley SE, Latsha R. Preoperative dobutamine stress echocardiography versus cardiac arteriography for risk assessment prior to renal transplantation. Transpl Int. 2000;13(suppl 1):S27-S30.
8. Marwick TH, Steinmuller DR, Underwood DA, Hobbs RE, Co RT, Swift C, Braun WE. Ineffectiveness of dipyridamole SPECT thallium imaging as a screening technique for coronary artery disease in patients with end-stage renal failure. Transplantation. 1990;49:100-103.
9. Dahan M, Viron BM, Faraggi M, Himbert DL, Legallicier BJJ, Kolta AM, Pessione F, De Guludec L, Gourgon R, Mignon FE. Diagnostic accuracy and prognostic value of combined dipyridamole-exercise thallium imaging in hemodialysis patients. Kidney Int. 1998;54:255-262.
10. Lewis MS, Wilson RA, Walker KW, Wilson DJ, Norman DJ, Barry JM, Bennett WM. Validation of an algorithm for predicting cardiac events in renal transplant candidates. Am J Cardiol. 2002;89:847-850.
11. Marwick TH, Herzog CA, Vandenberg BF, Rossen JD, Grove-McKay M. Evaluation of diabetic patients for renal and pancreas transplantation: noninvasive screening for coronary artery disease using radionuclide methods. Transplantation. 1966;62:1230-1235.
12. De Lima JJG, Abensur H, Krieger EM, Pilleggi F. Arterial blood pressure and left ventricular hypertrophy in hemodialysis patients. J Hypertens. 1996;14:1019-1024.
13. Warren SB, Newman TB, Cummings SR. Design a new study. III. Diagnostic tests. In: Hulley SB, Cummings SR, eds. Designing Clinical Research: An Epidemiological Approach. Baltimore, Md: Williams & Wilkins; 1988:87-97.
14. Kassiske BL, Guijarro C, Massy GA, Wiederkehr MR, Ma JZ. Cardiovascular disease after renal transplantation. J Am Soc Nephrol. 1996;7: 158-165.
15. Braun WE, Philips D, Vidt DG, Novick AC, Nakamoto S, Popowniak KL, Magnusson MO, Pohl MA, Steinmuller D, Provita D, Buszta C. Coronary arteriography and coronary artery disease in 99 diabetic and nondiabetic patients on chronic hemodialysis or renal transplant programs. Transplant Proc. 1998;13:128.
16. Mistry BM, Bastani B, Solomon H, Hoff J, Aridge DL, Lindsey LM, Schimid S, Chaitman BR, Garvin PJ. Prognostic value of dipyridamole thalium-201 screening to minimize perioperative cardiac complications in diabetics undergoing kidney or kidney-pancreas transplantation. Clin Sci. 1998;12:130-135.
17. Hunink MGM, Kuntz KM, Fleishmann KE, Brady TJ. Noninvasive imaging for the diagnosis of coronary artery disease: focusing the development of new diagnostic technology. Ann Intern Med. 1999;131:673-680.
18. Schimidt A, Stefenelli T, Schuster E, Mayer G. Informational contribution of noninvasive screening test for coronary artery disease in patients on chronic renal replacement therapy. Am J Kidney Dis. 2001; 37:56-63.
19. Holley JL, Fenton RA, Arthur RS. Thallium stress testing does not predict cardiovascular risk in diabetic patients with end-stage renal disease undergoing cadaveric renal transplantation. Am J Med. 1991;90:563-570.
20. Hogg D, Metcalfe M. The accuracy of non-invasive methods for the detection of obstructive coronary artery disease in the presence of left ventricular hypertrophy. J Hum Hypertens. 2000;14:295-298.
21. Boudreau RJ, Strony JT, du Cret RP, Kuni CC, Wag Y, Wilson RF, Schwartz JS, Castañeda-Zuniga WR. Perfusion thallium imaging of type 1 diabetes with end-stage renal disease: comparison of oral and intravenous dipyridamole administration. Radiology. 1990;175:103-105.
22. Brown JH, Vites NP, Testa HJ, Prescott MC, Hunt LP, Gokal R, Mallick NP. Value of thallium myocardium imaging in the prediction of future cardiovascular events in patients with end-stage renal failure. Nephrol Dial Transplant. 1993;8:433-437.
23. Marrow CE, Schwartz JS, Sutherland DE, Simmons RL, Ferguson RM, Kjellstrand CM, Najarian JS. Predictive value of thallium stress testing for coronary and cardiovascular events in uremic diabetic patients before renal transplantation. Am J Surg. 1983;146:331-335.
24. Camp AD, Garvin PJ, Hoff J, Marsh J, Byers SL, Chaitman BR. Prognostic value of intravenous dipyridamole thallium imaging in patients with diabetes mellitus considered for renal transplantation. Am J Cardiol. 1990;65:1459-1463.
25. Cottier C, Pfisterer M, Muller-Brand J, Thiel G, Burkart F. Cardiac evaluation of candidates for kidney transplant: value of exercise radionuclide angiography. Eur Heart J. 1990;11:832-838.
26. Derfler K, Kletter K, Balcke P, Heinz G, Dudczak R. Predictive value of thallium-201-dipyridamole stress scintigraphy in chronic hemodialysis patients and transplant recipients. Clin Nephrol. 1991;36:192-202.
27. De Lemos JA, Hillis LD. Diagnosis and management of coronary artery disease in patients with end-stage renal disease on hemodialysis. J Am Soc Nephrol. 1996;7:2044-2054.
28. Bates JR, Sawada SG, Segar DS, Spaedy AJ, Petrovic O, Fineberg NS, Feigenbaum H, Ryan T. Evaluation using dobutamine stress echocardiography in patients with insulin-dependent diabetes mellitus before kidney and/or pancreas transplantation. Am J Cardiol. 1996;77:175-179.
29. Brennan DC, Vedala G, Miller SG, Anstey ME, Singer GG, Kovacs A, Barzilai B, Lowell JA, Shenoy S, Howard TK, Davila-Roman VG. Pre-transplant dobutamine stress echocardiography is useful and cost-effective in renal transplant candidates. Transplant Proc. 1997;29:233-234.
30. Vandenberg BF, Rossen JD, Grover-McKay M, Shammas NW, Burns TL, Rezai K. Evaluation of diabetic patients for renal and pancreas transplant. Transplantation. 1996;62:1230-1235.
31. Marwick T, D'Hondt AM, Baudhuin T, Willemart B, Wijns W, Detry JM, Melin J. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy or both? J Am Coll Cardiol. 1993;22:159-167.